I. Stamenkovic

Discipline

Histoire, Philosophie et Sociologie des sciences (3) Economies et finances (2) Psychologie (1)

Type de document

Articles (37) Recensions (5) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

Cells (23) Expression (22) Observations (18) Observations (18) protéine (17) Human beings (17) Cancer (17) spectacle (14) gène (14) cancer (14) Cancer (14) Gene expression (14) Mice (13) tissu (corporel) (12) Sarcoma (12) Fusion (12) effet (11) survie (11) Survival (11) Proteins (11) Genes (10) Growth (10) Growth (10) Tumors--Growth (9) Tumors (9) Patients (9) Genetic regulation (9) Functions (9) Patients (9) Development (8)

Documents écrit par I. Stamenkovic (38) | parle de I. Stamenkovic (0)

Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity.
R. Sanalkumar et al. (31 mars 2023)
EWSR1-ATF1 dependent 3D connectivity regulates oncogenic and differentiation programs in Clear Cell Sarcoma.
E. Möller et al. (27 avr. 2022)
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia.
O. ElMokh et al. (8 avr. 2022)
Necrotic debris and STING exert therapeutically relevant effects on tumor cholesterol homeostasis.
S. Katakam et al.
A live single-cell reporter assay links intratumor heterogeneity to metastatic proclivity in Ewing sarcoma.
T. Keskin et al.
The chromatin landscape of primary synovial sarcoma organoids is linked to specific epigenetic mechanisms and dependencies.
G. Boulay et al.
Ewing's Sarcoma.
N. Riggi et al. (14 janv. 2021)
Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins.
S. Galland et al. (1 août 2020)
LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 Stability.
T. Keskin et al. (31 mars 2020)
Synovial sarcoma: when epigenetic changes dictate tumour development.
N. Riggi et al. (19 nov. 2018)
Epigenome editing of microsatellite repeats defines tumor-specific enhancer functions and dependencies.
G. Boulay et al. (1 août 2018)
Reciprocal modulation of mesenchymal stem cells and tumor cells promotes lung cancer metastasis.
G. Fregni et al.
Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets.
S. Galland et al. (19 sept. 2017)
IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer.
N. Degrauwe et al. (15 nov. 2016)
The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing.
N. Degrauwe et al. (24 mai 2016)
The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma.
L. Cironi et al. (24 févr. 2016)
Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-β (TGF-β) Activation and Fibroblast Differentiation.
C. Dayer et al. (2015)
EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.
N. Riggi et al. (10 nov. 2014)
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells.
M. Janiszewska et al.
Systematic identification of genomic markers of drug sensitivity in cancer cells.
M.J. Garnett et al. (2012)
Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma Development.
C. De Vito et al.
Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation.
L.A. Mauti et al. (2011)
Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer.
A. Planche et al. (2011)
EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells.
N. Riggi et al.
Transportin regulates nuclear import of CD44.
M. Janiszewska et al. (2010)

next